In an attempt to elucidate the role of CD123 in the pathogenesis of MDS and disease progression, Stevens et al. [40] showed that CD123+ on CD34+ hematopoietic stem cells in MDS exhibited significant changes in cellular energy metabolism and higher levels of protein synthesis [40]. The gene discussed is CD34; the disease is myelodysplastic syndrome.